SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

79,310.01 2,008.61
( 2.60%)

Global Indices

Nasdaq

53,347.89 1,540.17
(2.97%)

Dow Jones

7,717.41 127.49
(1.68%)

Hang Seng

60,935.13 -1,253.50
(-2.02%)

Nikkei 225

10,852.07 213.64
(2.01%)

Forex

USD-INR

94.73 -0.07
(-0.07%)

EUR-INR

105.99 -0.12
(-0.11%)

GBP-INR

127.06 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539523

INE540L01014

1170.8077615

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALKEM

27.69

62054.24

EPS(TTM)

Face Value()

Div & Yield %

187.45

1.02

Back

AGI Greenpac consolidated net profit rises 11.82% in the June 2026 quarter

Jul 29,2026

Net profit of AGI Greenpac rose 11.82% to Rs 99.35 crore in the quarter ended June 2026 as against Rs 88.85 crore during the previous quarter ended June 2025. Sales rose 14.19% to Rs 785.27 crore in the quarter ended June 2026 as against Rs 687.66 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	785.27	687.66	14
OPM %	22.26	20.65	-
PBDT	173.93	158.45	10
PBT	129.27	117.79	10
NP	99.35	88.85	12

79,310.01 2,008.61 ( 2.60%)

53,347.89 1,540.17 (2.97%)

7,717.41 127.49 (1.68%)

60,935.13 -1,253.50 (-2.02%)

10,852.07 213.64 (2.01%)

94.73 -0.07 (-0.07%)

105.99 -0.12 (-0.11%)

127.06 -0.04 (-0.03%)

0.60 0.00 (-0.31%)